Neuroenhancement with Vitamin B12-underestimated neurological significance

Nutrients

Volumn 5, Issue 12, 2013, Pages 5031-5045

  Gröber, Uwe ^a   Kisters, Klaus ^a,b   Schmidt, Joachim ^a  

^a Academy of Micronutrient Medicine   (Germany)

^b ST ANNA HOSPITAL   (Germany)

Author keywords

Brain atrophy; Diagnostic of Vitamin B12 deficiency; Elderly; Neuroenhancement; Vitamin B12; Vitamin B12 deficiency

Indexed keywords

CUBILIN; CYANOCOBALAMIN; FOLIC ACID; HOLOTRANSCOBALAMIN; HOMOCYSTEINE; METFORMIN; METHYLMALONIC ACID; OMEPRAZOLE; PYRIDOXINE; ROSIGLITAZONE; TRANSCOBALAMIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BRAIN ATROPHY; COGNITIVE DEFECT; COORDINATION DISORDER; CYANOCOBALAMIN DEFICIENCY; DEMENTIA; DIETARY INTAKE; DISEASE ASSOCIATION; HIGH RISK POPULATION; HUMAN; INCIDENCE; MALABSORPTION; MONONEUROPATHY; NERVE CONDUCTION; NEUROENHANCEMENT; NEUROLOGICAL AND SENSORIAL PROCEDURES; PARESTHESIA; RECOMMENDED DRUG DOSE; REVIEW; SENSORY DYSFUNCTION;

ALZHEIMER DISEASE; BRAIN; COGNITION; HOMOCYSTEINE; HUMANS; INCIDENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; S-ADENOSYLMETHIONINE; VITAMIN B 12; VITAMIN B 12 DEFICIENCY; VITAMIN B COMPLEX;

EID: 84890331264     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu5125031     Document Type: Review

References (44)

1. Gröber, U. Micronutrients: Metabolic Tuning-Prevention-Therapy. Drug Metab. Drug Interact. 2009, 24, 331, doi:10.1515/DMDI.2009.24.2-4.331.
2. Gröber, U. Interactions between drugs and micronutrients. Med. Monatsschr. Pharm. 2006, 29, 26-35.
3. Allen, L.H. How common is vitamin B-12 deficiency? Am. J. Clin. Nutr. 2009, 89, 693S-696S.
4. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and Its Panel on Folate, Other B Vitamins, and Choline and Subcommittee on Upper Reference Levels of Nutrients; Food and Nutrition Board; Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline; National Academy Press: Washington, DC, USA, 1998.
5. Healton, E.B.; Savage, D.G. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore) 1991, 70, 229-245.
6. Neurologic Manifestations Related to Deficiency of Vitamin B12. Available online: http://yassermetwally.com/blog/?p=194 (accessed on 10 December 2013).
7. Sethi, N.K.; Robilotti, E.; Sadan, Y. Neurological manifestations of Vitamin B12 deficiency. Internet J. Nutr. Wellness 2005, 2, 1-12.
8. Lorenzl, S.; Vogeser, M.; Müller-Schunk, S. Clinically and MRI documented funicular myelosis in a patient with metabolical Vitamin B12 deficiency but normal Vitamin B12 serum level. J. Neurol. 2003, 250, 1010-1011.
9. Dror, D.K.; Allen, L.H. Effect of Vitamin B12 deficiency on neurodevelopment in infants: Current knowledge and possible mechanisms. Nutr. Rev. 2008, 66, 250-255.
10. Dali-Youcef, N.; Andres, E. An update on cobalamin deficiency in adults. QJM 2009, 102, 17-28.
11. Herrmann, W.; Obeid, R. Functional Vitamin B12 deficiency and determination of holotranscobalamin in populations at risk. Clin. Chem. Lab. Med. 2003, 41, 1478-1488.
12. Nexo, E.; Hoffmann-Lucke, E. Holotranscobalamin, a marker of vitamin B-12 status: Analytical aspects and clinical utility. Am. J. Clin. Nutr. 2011, 94, 359S-365S.
13. Schrempf, W.; Eulitz, M.; Neumeister, V.; Siegert, G.; Koch, R.; Reichmann, H.; Storch, A. Utility of measuring Vitamin B12 and its active fraction, holotranscobalamin, in neurological Vitamin B12 deficiency syndromes. J. Neurol. 2011, 258, 393-401.
14. Lindenbaum, J.; Savage, D.G. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am. J. Hematol. 1990, 34, 99-107.
15. Troxler, H.; Hersberger, M.; Baumgartner, M. Methylmalonsäure zur bestimmung des Vitamin B12-mangels. Schweiz. Med. Forum 2008, 8, 823-825 (in German).
16. Savage, D.G.; Lindenbaum, J. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am. J. Med. 1994, 96, 239-246.
17. Nationale Verzehrsstudie II (National Nutrtion Survey II), 2008. Available online: http://www.nationale-verzehrsstudie.de (accessed on 4 December 2013).
18. Herrmann, W.; Obeid, R. The usefulness of holotranscobalamin in predicting Vitamin B12 status in different clinical settings. Curr. Drug Metab. 2005, 6, 47-53.
19. Coelhoo, D.; Suormala, T.; Stucki, M.; Lerner-Ellis, J.P.; Rosenblatt, D.S.; Newbold, R.F.; Baumgartner, M.R.; Fowler, B. Gene identification for the cblD defect of Vitamin B12 metabolism. N. Engl. J. Med. 2008, 358, 1454-1464.
20. Obeid, R.; Schorr, H.; Eckert, R.; Herrmann, W. Vitamin B12 status in the elderly as judged by available biochemical markers. Clin. Chem. 2004, 50, 238-241.
21. Kaptan, K.; Beyan, C.; Ural, A.U. Helicobacter pylori-Is it a novel causative agent in Vitamin B12 deficiency? Arch. Intern. Med. 2000, 160, 1349-1353.
22. Seal, E.C.; Metz, J.; Flicker, L. A randomized, double-blind, placebo-controlled study of oral Vitamin B12 supplementation in older patients with subnormal or borderline serum Vitamin B12 concentrations. J. Am. Geriatr. Soc. 2002, 50, 146-151.
23. De Jager, J.; Kooy, A.; Lehert, P. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: Randomised placebo controlled trial. BMJ 2010, 340, doi:10.1136/bmj.c2181.
24. Sahin, M. Effects of metformin or rosiglitazone on serum concentrations of homocysteine, folate, and Vitamin B12 in patients with type 2 diabetes mellitus. J. Diabetes Complicat. 2007, 21, 118-123.
25. Ting, R.Z. Risk factors of vitamin B(12) deficiency in patients receiving metformin. Arch. Intern. Med. 2006, 166, 1975-1979.
26. Moore, E.M.; Mander, A.G.; Ames, D.; Kotowicz, M.A.; Carne, R.P.; Brodaty, H.; Woodward, M.; Boundy, K.; Ellis, K.A.; Bush, A.I.; et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care 2013, 36, 2981-2987.
27. Henoun Loukili, N.; Noel, E. Cobalamin deficiency due to non-immune atrophic gastritis in elderly patients. A report of 25 cases. J. Nutr. Health Aging 2005, 9, 462.
28. Herrmann, W.; Schorr, H. Vitamin B-12 status, particularly holotranscobalamin II and methylmalonic acid concentrations, and hyperhomocysteinemia in vegetarians. Am. J. Clin. Nutr. 2003, 78, 131-136.
29. Lücke, T.; Korenke, G.C. Mütterlicher Vitamin-B12-Mangel: Ursache neurologischer Symptomatik im Säuglingsalter. Z. Geburtshilfe Neonatol. 2007, 211, 157-161 (in German).
30. Solomon, L.R. Disorders of cobalamin (Vitamin B12) metabolism: Emerging concepts in pathophysiology, diagnosis and treatment. Blood Rev. 2007, 21, 113-130.
31. Pietrzik, K.; Golly, I.; Loew, D. Handbuch der Vitamine. Für Prophylaxe, Beratung und Therapie (in German), 1st ed.; Urban & Fischer: Munich, Germany, 2008; pp. 126-146.
32. Eussen, S.J.; de Groot, L.C. Oral cyanocobalamin supplementation in older people with Vitamin B12 deficiency: A dose-finding trial. Arch. Intern. Med. 2005, 165, 1167-1172.
33. Vidal-Alaball, J.; Butler, P.P. Oral Vitamin B12 versus intramuscular Vitamin B12 for Vitamin B12 deficiency. Cochrane Database Syst. Rev. 2009, 3, CD004655.
34. Vogiatzoglou, A. Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology 2008, 71, 826-832.
35. Riggs, K.M. Relations of Vitamin B-12, Vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am. J. Clin. Nutr. 1996, 63, 306-314.
36. Blasko, I.; Hinterberger, M.; Kemmler, G. Conversion from mild cognitive impairment to dementia: Influence of folic acid and Vitamin B12 use in the VITA cohort. J. Nutr. Health Aging 2012, 16, 687-694.
37. Vogiatzoglou, A.; Smith, A.D.; Nurk, E. Cognitive function in an elderly population: Interaction between Vitamin B12 status, depression, and apolipoprotein E s4: The Hordaland Homocysteine Study. Psychosom. Med. 2013, 75, 20-29.
38. Budge, M. Plasma total homocysteine and cognitive performance in a volunteer elderly population. Ann. N. Y. Acad. Sci. 2000, 903, 407-410.
39. Seshadri, S. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 2002, 346, 476-483.
40. Den Heijer, H. Homocysteine and brain atrophy on MRI of non-demented elderly. Brain 2003, 126, 170-175.
41. Williams, J.H. Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people. Age Ageing 2002, 31, 440-444.
42. Scott, T.M. Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders. Am. J. Geriatr. Psychiatry 2004, 12, 631-638.
43. Smith, A.D. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial. PLoS One 2010, 5, e12244.
44. Douaud, G.; Refsum, H.; de Jager, C.A.; Jacoby, R.; Nichols, T.E.; Smith, S.M.; Smith, A.D. Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment. Proc. Natl. Acad. Sci. USA 2013, 110, 9523-9528.